Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Ossenkoppele

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|December 1, 1995
High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility studyA R Jonkhoff, M A Plaizier, G J Ossenkoppele, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myelomaC A Uyl-de Groot, G J Ossenkoppele, A A van Riet, et al.
Leukemia|April 8, 2017
Measurable residual disease testing in acute myeloid leukaemiaC S Hourigan, R P Gale, N J Gormley, et al.
European Journal of Haematology|October 1, 1993
Therapeutic potential of intravenous 67-gallium in non-Hodgkin's lymphomaP C Huijgens, A R Jonkhoff, O S Hoekstra, et al.
Blood|February 15, 1989
Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiationP W Wijermans, V I Rebel, G J Ossenkoppele, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2001
Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemiaM C Legdeur, M G Broekhoven, G J Schuurhuis, et al.
Leukemia Research|January 1, 1989
Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducerG J Ossenkoppele, P W Wijermans, J J Nauta, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1998
New strategies in hematopoietic stem cell transplantation: G-CSF-mobilized unprocessed whole bloodA M Dräger, G J Ossenkoppele, A R Jonkhoff, et al.
The Netherlands Journal of Medicine|October 1, 1989
Standard induction and low dose ara-C treatment in patients over 60 with AML or MDSB M van Geel, P C Huijgens, G J Ossenkoppele, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2002
[STI571: a new dimension in the treatment of chronic myeloid leukemia]J A E Somers, S O A Shamelian, B Löwenberg, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|December 1, 1995
High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility studyA R Jonkhoff, M A Plaizier, G J Ossenkoppele, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myelomaC A Uyl-de Groot, G J Ossenkoppele, A A van Riet, et al.
Leukemia|April 8, 2017
Measurable residual disease testing in acute myeloid leukaemiaC S Hourigan, R P Gale, N J Gormley, et al.
European Journal of Haematology|October 1, 1993
Therapeutic potential of intravenous 67-gallium in non-Hodgkin's lymphomaP C Huijgens, A R Jonkhoff, O S Hoekstra, et al.
Blood|February 15, 1989
Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiationP W Wijermans, V I Rebel, G J Ossenkoppele, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2001
Monocyte-chemoattractant-protein-1-mediated migration of human monocytes towards blasts from patients with acute myeloid leukemiaM C Legdeur, M G Broekhoven, G J Schuurhuis, et al.
Leukemia Research|January 1, 1989
Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducerG J Ossenkoppele, P W Wijermans, J J Nauta, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1998
New strategies in hematopoietic stem cell transplantation: G-CSF-mobilized unprocessed whole bloodA M Dräger, G J Ossenkoppele, A R Jonkhoff, et al.
The Netherlands Journal of Medicine|October 1, 1989
Standard induction and low dose ara-C treatment in patients over 60 with AML or MDSB M van Geel, P C Huijgens, G J Ossenkoppele, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2002
[STI571: a new dimension in the treatment of chronic myeloid leukemia]J A E Somers, S O A Shamelian, B Löwenberg, et al.
Pageof 19